The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Immune Reconstitution in HIV‐Infected Patients
Open accessAbstract
The prognosis of patients infected with human immunodeficiency virus (HIV) type 1 has dramatically improved since the advent of potent antiretroviral therapies (ARTs), which have enabled sustained suppression of HIV replication and recovery of CD4 T cell counts. Knowledge of the function of CD4 T cells in immune reconstitution was derived from large clinical studies demonstrating that primary and secondary prophylaxis against infectious agents, such as Pneumocystis jirovecii (Pneumocystis carinii), Mycobacterium avium complex, cytomegalovirus, and other pathogens, can be discontinued safely once CD4 T cell counts have increased beyond pathogen-specific threshold levels (usually >200 CD4 T cells/mm3) for 3-6 months. The downside of immune reconstitution is an inflammatory syndrome occurring days to months after the start of ART, with outcomes ranging from minimal morbidity to fatal progression. This syndrome can be elicited by infectious and noninfectious antigens. Microbiologically, the possible pathogenic pathways involve recognition of antigens associated with ongoing infection or recognition of persisting antigens associated with past (nonreplicating) infection. Specific antimicrobial therapy, nonsteroidal anti-inflammatory drugs, and/or steroids for managing immune reconstitution syndrome should be considered.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Palella, F. J., Delaney, K. M., Moorman, A. C., Loveless, M. O., Fuhrer, J., Satten, G. A., Aschman, D. J., & Holmberg, S. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199803263381301 · Cited by 9,405
Autran, B., Carcelain, G., Li, T. S., Blanc, C., Mathez, D., Tubiana, R., Katlama, C., Debré, P., & Leibowitch, J. (1997) · Science · doi:10.1126/science.277.5322.112 · Cited by 1,785
Egger, M., May, M., Chêne, G., Phillips, A. N., Ledergerber, B., Dabis, F., Costagliola, D., Monforte, A. D., de Wolf, F., Reiss, P., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09411-4 · Cited by 1,525
Sulkowski, M. S. (2000) · JAMA · doi:10.1001/jama.283.1.74 · Cited by 950
Pakker, N. G., Notermans, D. W., De Boer, R. J., Roos, M. T. L., Wolf, F. D., Hill, A., Leonard, J. M., Danner, S. A., Miedema, F., & Schellekens, P. T. A. (1998) · Nature Medicine · doi:10.1038/nm0298-208 · Cited by 701
Hirsch, H. H., & Steiger, J. (2003) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(03)00770-9 · Cited by 662
Self-citationEgger, M., Hirschel, B., Francioli, P., Sudre, P., Wirz, M., Flepp, M., Rickenbach, M., Malinverni, R., Vernazza, P., & Battegay, M. (1997) · BMJ · doi:10.1136/bmj.315.7117.1194 · Cited by 615
Self-citationParadoxical Worsening of Tuberculosis Following Antiretroviral Therapy in Patients with AIDS
NARITA, M., ASHKIN, D., HOLLENDER, E. S., & PITCHENIK, A. E. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.158.1.9712001 · Cited by 608
Masur, P. B. H., Kaplan, J. E., & Holmes, K. K. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-5_part_2-200209031-00002 · Cited by 567
HIV viral load markers in clinical practice
Saag, M. S., Holodniy, M., Kuritzkes, D. R., O'Brien, W. A., Coombs, R., Poscher, M. E., Jacobsen, D. M., Shaw, G. M., Richman, D. D., & Volberding, P. A. (1996) · Nature Medicine · doi:10.1038/nm0696-625 · Cited by 524
Cited by
Raltegravir with Optimized Background Therapy for Resistant HIV-1 Infection
Steigbigel, R. T., Cooper, D. A., Kumar, P. N., Eron, J. E., Schechter, M., Markowitz, M., Loutfy, M. R., Lennox, J. L., Gatell, J. M., Rockstroh, J. K., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0708975 · Cited by 691
Shelburne, S. A., Visnegarwala, F., Darcourt, J., Graviss, E. A., Giordano, T. P., White, A. C., & Hamill, R. J. (2005) · AIDS · doi:10.1097/01.aids.0000161769.06158.8a · Cited by 632
The 1918 Influenza Pandemic: Insights for the 21st Century
Morens, D. M., & Fauci, A. S. (2007) · The Journal of Infectious Diseases · doi:10.1086/511989 · Cited by 536
Shiohara, T., Inaoka, M., & Kano, Y. (2006) · Allergology International · doi:10.2332/allergolint.55.1 · Cited by 485
Histological Patterns of Polyomavirus Nephropathy: Correlation with Graft Outcome and Viral Load
Drachenberg, C. B., Papadimitriou, J. C., Hirsch, H. H., Wali, R., Crowder, C., Nogueira, J., Cangro, C. B., Mendley, S., Mian, A., & Ramos, E. (2004) · American Journal of Transplantation · doi:10.1046/j.1600-6143.2004.00603.x · Cited by 406
Self-citationClinical implications of HIV and hepatitis B co-infection in Asia and Africa
Hoffmann, C. J., & Thio, C. L. (2007) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70135-4 · Cited by 345
Lortholary, O., Fontanet, A., Mémain, N., Martin, A., Sitbon, K., & Dromer, F. (2005) · AIDS · doi:10.1097/01.aids.0000174450.70874.30 · Cited by 324
Kaufmann, G. R., Furrer, H., Ledergerber, B., Perrin, L., Opravil, M., Vernazza, P., Cavassini, M., Bernasconi, E., Rickenbach, M., Hirschel, B., et al. (2005) · Clinical Infectious Diseases · doi:10.1086/431484 · Cited by 313
Self-citationShelburne, III, Darcourt, J., White, Jr., Greenberg, S. B., Hamill, R. J., Atmar, R. L., & Visnegarwala, F. (2005) · Clinical Infectious Diseases · doi:10.1086/428618 · Cited by 305
Immune reconstitution inflammatory syndrome: more answers, more questions
Shelburne, S. A., Montes, M., & Hamill, R. J. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki444 · Cited by 286
Back to the Future: Lessons Learned From the 1918 Influenza Pandemic
Short, K. R., Kedzierska, K., & van de Sandt, C. E. (2018) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2018.00343 · Cited by 278
Immunological recovery and antiretroviral therapy in HIV-1 infection
Battegay, M., Nüesch, R., Hirschel, B., & Kaufmann, G. R. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70463-7 · Cited by 255
Self-citationClinical manifestations of tuberculosis in children
Cruz, A. T., & Starke, J. R. (2007) · Paediatric Respiratory Reviews · doi:10.1016/j.prrv.2007.04.008 · Cited by 204
The effect of HAART on salivary microbiota in the women's Interagency HIV study (WIHS)
Navazesh, M., Mulligan, R., Pogoda, J., Greenspan, D., Alves, M., Phelan, J., Greenspan, J., & Slots, J. (2005) · Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology · doi:10.1016/j.tripleo.2004.10.011 · Cited by 33
Metadata
- Authors
- Hirsch, H. H., Kaufmann, G., Sendi, P., & Battegay, M.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-04-15
- Volume
- 38
- Issue
- 8
- Pages
- 1159-1166
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2171034892
- Cited by
- 327
- References
- 64
- FWCI
- 12.19
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.